Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

TherapeuticsMD (TXMD) Short-Term Debt issuances (2020)

TherapeuticsMD filings provide 4 years of Short-Term Debt issuances readings, the most recent being $50.0 million for Q1 2020.

On a quarterly basis, Short-Term Debt issuances changed N/A to $50.0 million in Q1 2020 year-over-year; TTM through Dec 2020 was $50.0 million, a N/A change, with the full-year FY2020 number at $50.0 million, down 75.0% from a year prior.
Short-Term Debt issuances hit $50.0 million in Q1 2020 for TherapeuticsMD, up from $100000.0 in the prior quarter.
In the past five years, Short-Term Debt issuances ranged from a high of $50.0 million in Q1 2020 to a low of $50.0 million in Q1 2020.